ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0024

Heterogeneity of Inflammatory HLA-DR+ Synovial Fibroblasts in Rheumatoid Arthritis Is Driven by Responses to Leukocyte-Derived Cytokines

Melanie Smith1, Alejandro Kochen1, Vianne Gao2, Michail Schizas2, Edward DiCarlo1, Susan Goodman1, Christina Leslie3, Laura Donlin1 and Alexander Rudensky4, 1Hospital for Special Surgery, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY, 3Computational and Systems Biology Program Memorial Sloan Kettering Cancer Center, New York, NY, 4Memorial Sloan Kettering Cancer Center / Howard Hughes Medical Institute, New York, NY

Meeting: ACR Convergence 2021

Keywords: Fibroblasts, Synovial, immunology, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: RA – Etiology & Pathogenesis Poster (0011–0045)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Treatment-refractory rheumatoid arthritis (RA) represents a major unmet need with substantial societal burden. Targeting RA-associated fibroblast-like synoviocytes (FLS) may provide a less-immunosuppressive therapeutic option. Recent single cell RNA-sequencing (scRNA-seq) studies of RA synovial tissue have identified distinct fibroblast subsets, including a population of HLA-DR+ FLS that are expanded in RA and express pro-inflammatory cytokines as well as interferon gamma (IFNg) and tumor necrosis factor alpha (TNFa) response signatures (1). Donors with an expansion of HLA-DR+ FLS have an expansion of inflammatory monocytes, which express interleukin 1 beta (IL-1b), and CD8+ T cells, which express both TNFa and IFNg (1). TNFa stimulated macrophages that produce IL-1b induce key genes expressed by HLA-DR+ FLS, including IL6 (2). Here we explored the ability of distinct combinations of cytokines predominant in RA to impart gene expression features observed in HLA-DR+ FLS and localize these FLS within the inflamed synovium.

Methods: Synovial tissue was obtained from a prospective cohort of RA patients undergoing arthroplasty or synovectomy who are screened for active RA at the time of surgery (HSS IRB no. 2014-233). For cultured FLS, synovial tissue was dissociated and cultured as in (2). FLS were cultured with cytokines for 24 hours. ScRNA-seq was performed on sorted FLS (CD45–, CD31–, PDPN+) from dissociated synovial tissue. Multiparameter immunofluorescence (IF) was carried out using Iterative Bleaching Extends Multiplexity (IBEX) (3).

Results: The combination of IFNg, TNFa +/- IL-1b induced FLS expression of genes characteristic of HLA-DR+ FLS such as IL6, CCL2, CXCL9 and ICAM1 (Fig 1A). Differential gene expression analysis of cytokine-stimulated FLS revealed distinct transcriptional features elicited by IFNg + TNFa vs IL-1b (Fig 1B). When used in combination, the cytokines were able to exert a synergistic effect on FLS gene expression with a small set of genes induced by the combination of all three cytokines (IL6, TNFAIP6, MT2A, CCL2, MT1E). Unsupervised clustering analysis of gene expression of freshly dissociated FLS shows heterogeneity of HLA-DR+ FLS with expression in both lining and sublining clusters as well as in clusters with an intermediate lining/sublining phenotype (Fig 2A). Clusters have differential expression of genes driven by TNFa + IFNg (CXCL9), IL-1b (MMP3) or all three cytokines (CCL2) (Fig 2B). IF analysis of inflamed synovium revealed localization of HLA-DR+ FLS to both the lining and sublining areas in proximity to CD68+ macrophages and CD8+ T cells, respectively, (Fig 3).

Conclusion: Pro-inflammatory cytokine exposure of FLS accounts in part for the HLA-DR+ FLS heterogeneity observed in the arthritic synovium in situ. Our analyses suggest that gene expression patterns observed in HLA-DR+ FLS, which we were able to reconstruct with combinatorial cytokine stimulation in vitro, may originate from interacting CD8+ T cells and inflammatory macrophages in the synovium.

References:
1) Zhang F, et al. Nat Immunol. 2019;20(7):928.
2) Kuo D, et al. Sci Transl Med. 2019;11(491):eaau8587.
3) Radtke AJ, et al. Proc Natl Acad Sci U S A. 2020;117(52):33455.

Figure 1. Stimulation of cultured FLS with combinations of dominant RA cytokines reveals marked synergy and distinct gene signatures driven by either TNFa + IFNg ± IL_1b. A. qPCR on cultured, cytokine-stimulated FLS. n = 3 donors. Mean ± SD. B. Differential expression analysis from scRNA-seq of cultured, cytokine-stimulated FLS derived from single RF+/CCP+ patient on methotrexate monotherapy with active disease.

Figure 2. Heterogeneity of HLA-DR+ FLS including clusters with expression of genes induced cytokine combinations. ScRNA-seq of freshly dissociated, sorted FLS from same patient as in Fig 1. A. t-SNE showing clusters of transcriptionally similar FLS in which clusters 2 and 3 are lining, 5 and 7 are intermediate sublining/lining and 0, 1, 4, 6, 8, and 9 are sublining. B. Expression of HLA-DRA as well as genes induced by IFNg + TNFa (CXCL9), IL_1b (MMP3) or IFNg + TNFa + IL_1b (CCL2).

Figure 3. HLA-DR+ FLS are found within both synovial sublining and lining. IF of RA synovial tissue from same patient as in Fig 1 and 2 where HLA-DR+ FLS can be found near both CD68+ macrophages (arrow heads) and CD8+ T cells (arrows). Black space in full sized image represents synovial fluid space between two hypertrophied villi of the inflamed synovium.


Disclosures: M. Smith, None; A. Kochen, None; V. Gao, None; M. Schizas, None; E. DiCarlo, None; S. Goodman, UCB, 1, NOvartis, 5; C. Leslie, None; L. Donlin, Karius, Inc., 5, Stryker, 2, 6; A. Rudensky, Takeda, 5, 10, Surface Oncology, 2, 11, RAPT Therapeutics, 2, 11, Sonoma Biotherapeutics, 2, 11, Vedanta Biosciences, 2, 11, BioInvent AB, 2.

To cite this abstract in AMA style:

Smith M, Kochen A, Gao V, Schizas M, DiCarlo E, Goodman S, Leslie C, Donlin L, Rudensky A. Heterogeneity of Inflammatory HLA-DR+ Synovial Fibroblasts in Rheumatoid Arthritis Is Driven by Responses to Leukocyte-Derived Cytokines [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/heterogeneity-of-inflammatory-hla-dr-synovial-fibroblasts-in-rheumatoid-arthritis-is-driven-by-responses-to-leukocyte-derived-cytokines/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/heterogeneity-of-inflammatory-hla-dr-synovial-fibroblasts-in-rheumatoid-arthritis-is-driven-by-responses-to-leukocyte-derived-cytokines/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology